May 31st 2024
FDA approves Moderna's RSV vaccine for seniors, young women struggling with recurrent C difficile over the years, FDA grants Karius test to assist diagnosing infectious diseases, and more this week from Contagion.
WHO Updates Recommendations for HIV, Hepatitis, STI Interventions in Prisons
July 26th 2023The update refreshes the organization's 2022 guidance on HIV, viral hepatitis, and STI prevention, diagnosis, treatment, and care for key populations, focusing on people in prisons and other closed settings.
Read More
As the Adenovirus-Induced Hepatitis Mystery Continues, an Understanding of Testing is Vital
June 25th 2023Clinicians should consider adenovirus testing in pediatric patients with hepatitis of unknown etiology. Here is an update on the incidence rates and lab diagnostics associated with identifying the virus.
Read More
Working Towards HBV Cure, Company Presents Vaccine Data at Liver Conference
June 22nd 2023Biopharmaceutical company, Vaccitech, has developed its VTP-300 vaccine, and is presenting a poster demonstrating positive early data at the ongoing European Association for the Study of the Liver (EASL) Congress 2023.
Read More
The innovative antibiotic Xacduro has received FDA approval for its efficacy against ventilator-associated bacterial pneumonia caused by Acinetobacter baumannii-calcoaceticus. The intravenous therapy combines sulbactam and durlobactamto target multidrug-resistant and carbapenem-resistant strains.
Read More
FDA Approves Paxlovid for COVID-19 in Adults, Continues Strategy to Minimize Infection Severity
May 25th 2023This is the first oral antiviral to get through the regulatory process and is indicated for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.
Read More